|
121 |
Development of the Good Health Research Practice course: ensuring quality across all health research in humans
Enthalten in Health research policy and systems Bd. 15, 31.3.2017, Nr. 1, date:12.2017: 1-4
|
|
|
|
122 |
Distant delivery of a mindfulness-based intervention for people with Parkinson’s disease: the study protocol of a randomised pilot trial
Enthalten in Pilot and feasibility studies Bd. 3, 16.1.2017, Nr. 1, date:12.2017: 1-13
|
|
|
|
123 |
Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov
Enthalten in Orphanet journal of rare diseases Bd. 12, 2.3.2017, Nr. 1, date:12.2017: 1-20
|
|
|
|
124 |
DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes
Enthalten in Cardiovascular diabetology Bd. 16, 10.2.2017, Nr. 1, date:12.2017: 1-7
|
|
|
|
125 |
Effect sizes in ongoing randomized controlled critical care trials
Enthalten in Critical care Bd. 21, 5.6.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
126 |
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial
Enthalten in BMC neurology Bd. 17, 10.1.2017, Nr. 1, date:12.2017: 1-11
|
|
|
|
127 |
Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials
Enthalten in BMC nephrology Bd. 18, 30.6.2017, Nr. 1, date:12.2017: 1-11
|
|
|
|
128 |
Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis
Enthalten in Cardiovascular diabetology Bd. 16, 27.2.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
129 |
Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data
Enthalten in Cardiovascular diabetology Bd. 16, 21.3.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
130 |
Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial
Enthalten in BMC musculoskeletal disorders Bd. 18, 30.8.2017, Nr. 1, date:12.2017: 1-10
|
|
Administration
